HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Albert Pinhasov Selected Research

Medulloblastoma

5/2021Differences in RNA and microRNA Expression Between PTCH1- and SUFU-mutated Medulloblastoma.
1/2018MicroRNA-mRNA expression profiles associated with medulloblastoma subgroup 4.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Albert Pinhasov Research Topics

Disease

5Inflammation (Inflammations)
06/2022 - 03/2003
5Neoplasms (Cancer)
06/2022 - 09/2016
3Melanoma (Melanoma, Malignant)
09/2021 - 09/2016
3Body Weight (Weight, Body)
01/2021 - 01/2012
2Medulloblastoma
05/2021 - 01/2018
2Mood Disorders (Mood Disorder)
01/2020 - 11/2008
2Atopic Dermatitis (Atopic Eczema)
01/2020 - 12/2017
1Infections
06/2022
1Basal Cell Carcinoma (Rodent Ulcer)
05/2021
1Animal Diseases
01/2021
1Paranoid Disorders (Paranoia)
01/2020
1Schizophrenia (Dementia Praecox)
01/2020
1Hypoglycemia (Reactive Hypoglycemia)
11/2019
1Splenomegaly
11/2019
1Carcinogenesis
01/2018
1Psoriasis (Pustulosis Palmaris et Plantaris)
12/2017
1Dermatitis
12/2017
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
07/2016
1Muscular Dystrophies (Muscular Dystrophy)
07/2016
1Polydipsia
02/2016
1Cognitive Dysfunction
05/2015
1Major Depressive Disorder (Major Depressive Disorders)
01/2015
1Coma (Comas)
10/2012
1Heat Stroke (Heatstroke)
10/2012
1Depressive Disorder (Melancholia)
01/2011
1Confusion (Bewilderment)
01/2007
1Parkinson Disease (Parkinson's Disease)
01/2006
1Fetal Alcohol Spectrum Disorders
06/2004
1Fetal Death
06/2004
1Craniocerebral Trauma (Head Injury)
03/2003
1Colonic Neoplasms (Colon Cancer)
10/2002
1Lung Neoplasms (Lung Cancer)
10/2002

Drug/Important Bio-Agent (IBA)

4Peptides (Polypeptides)IBA
01/2017 - 03/2003
3Cyclic PeptidesIBA
06/2022 - 01/2017
3IntegrinsIBA
09/2021 - 09/2016
3Brain-Derived Neurotrophic Factor (BDNF)IBA
12/2017 - 11/2008
3Antidepressive Agents (Antidepressants)IBA
01/2015 - 01/2007
2CytokinesIBA
06/2022 - 11/2019
2RNA (Ribonucleic Acid)IBA
05/2021 - 01/2018
2MicroRNAs (MicroRNA)IBA
05/2021 - 01/2018
2CannabinoidsIBA
01/2020 - 01/2020
2Messenger RNA (mRNA)IBA
01/2018 - 03/2003
2Pharmaceutical PreparationsIBA
01/2017 - 01/2007
2Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
01/2011 - 11/2008
1ChemokinesIBA
06/2022
1InterferonsIBA
06/2022
1Tumor Biomarkers (Tumor Markers)IBA
09/2021
1Connexin 30IBA
05/2021
1Metalloproteases (Metalloproteinases)IBA
05/2021
1AdipokinesIBA
01/2021
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2020
1Immunoglobulin E (IgE)IBA
01/2020
1Anti-Anxiety Agents (Anxiolytics)IBA
01/2020
1Biological ProductsIBA
01/2020
1Insulin (Novolin)FDA Link
11/2019
1Insulin-Like Growth Factor I (IGF-1)IBA
11/2019
1Interleukin-6 (Interleukin 6)IBA
11/2019
1alanyl-glycyl-serineIBA
01/2017
1hydroxide ionIBA
01/2017
1Topoisomerase I InhibitorsIBA
01/2017
1Amino AcidsFDA Link
01/2017
1Caspase 3 (Caspase-3)IBA
01/2017
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2017
1CamptothecinIBA
01/2017
1leucyl-phenylalanineIBA
01/2017
1Sucrose (Saccharose)IBA
02/2016
1AcidsIBA
05/2015
1RimonabantIBA
01/2012
1Nerve Growth Factors (Neurotrophins)IBA
11/2008
1Antimanic AgentsIBA
01/2007
1SynucleinsIBA
01/2006
1Proteins (Proteins, Gene)FDA Link
01/2006
1ApolipoproteinsIBA
06/2004
1SALLRSIPAIBA
06/2004
1Neuroprotective AgentsIBA
03/2003
1stearyl- Nle(17)- neurotensin(6- 11)VIP(7- 28)IBA
10/2002
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
10/2002
1Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA
10/2002

Therapy/Procedure

2Injections
09/2016 - 03/2003
1Radiotherapy
05/2021
1Therapeutics
01/2021
1Ligation
07/2016
1General Anesthesia
10/2012
1Emergency Treatment
10/2012
1Aftercare (After-Treatment)
06/2004